BFM
CNTB

Boothbay Fund Management’s Connect Biopharma Holdings CNTB Stock Holding History

Boothbay Fund Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.9K Hold
37,000
– – ﹤0.01% 1879
2025
Q4 		$104K Buy
+37,000
New +$78.9K ﹤0.01% 1735

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Boothbay Fund Management's CNTB Position: Q1 2026 in Review

Boothbay Fund Management held its Connect Biopharma Holdings (CNTB) position steady in Q1 2026 at 1,234,582 shares worth $3.23M. The position accounts for 0.04% of the portfolio, ranked #447.

Boothbay Fund Management first reported a position in CNTB in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.48M in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Boothbay Fund Management held 1,234,582 shares of Connect Biopharma Holdings worth $3.23M as of Q1 2026.
  • Boothbay Fund Management left its Connect Biopharma Holdings share count unchanged in Q1 2026.
  • Connect Biopharma Holdings made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #447 holding.
  • Boothbay Fund Management first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 9 quarters since.
  • Boothbay Fund Management's Connect Biopharma Holdings position peaked at $3.48M in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.